Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lieselot van Erven

Showing results (31-40 of 120) with videos related to

Pageof 12
Sort By:
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 24, 2009
Requirement for coronary sinus lead interventions and effectiveness of endovascular replacement during long-term follow-up after implantation of a resynchronization deviceC Jan Willem Borleffs, Rutger J van Bommel, Sander G Molhoek, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 12, 2026
Updated Dutch guideline for management of radiation oncology patients with a pacemaker, implantable cardioverter defibrillator or non-cardiac active implantWim P A Jansen, Phil W Koken, Renske A de Jong, et al.
The American Journal of Cardiology|September 3, 2016
Long-Term Echocardiographic Outcome in Super-Responders to Cardiac Resynchronization Therapy and the Association With Mortality and Defibrillator TherapyAafke C van der Heijden, Ulas Höke, Joep Thijssen, et al.
Heart Rhythm|March 3, 2009
Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapyC Jan Willem Borleffs, Claudia Ypenburg, Rutger J van Bommel, et al.
Journal of Cardiovascular Electrophysiology|July 23, 2011
Primary prevention implantable cardioverter defibrillator recipients: the need for defibrillator back-up after an event-free first battery service-lifeGuido H Van Welsenes, Johannes B Van Rees, Joep Thijssen, et al.
The American Journal of Cardiology|August 6, 2002
Effectiveness of resynchronization therapy in patients with end-stage heart failureSander G Molhoek, Jeroen J Bax, Lieselot van Erven, et al.
Journal of the American College of Cardiology|January 29, 2011
Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortalityJohannes B van Rees, C Jan Willem Borleffs, Mihály K de Bie, et al.
European Heart Journal|January 25, 2012
Predictors of long-term benefit of cardiac resynchronization therapy in patients with right bundle branch blockDarryl P Leong, Ulas Höke, Victoria Delgado, et al.
The American Journal of Cardiology|March 31, 2004
Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathySander G Molhoek, Jeroen J Bax, Lieselot van Erven, et al.
Journal of Cardiovascular Electrophysiology|July 14, 2006
Serial reevaluation for ARVD/C is indicated in patients presenting with left bundle branch block ventricular tachycardia and minor ECG abnormalitiesPhilippine Kiès, Marianne Bootsma, Jeroen J Bax, et al.
Pageof 12

Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 24, 2009
Requirement for coronary sinus lead interventions and effectiveness of endovascular replacement during long-term follow-up after implantation of a resynchronization deviceC Jan Willem Borleffs, Rutger J van Bommel, Sander G Molhoek, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 12, 2026
Updated Dutch guideline for management of radiation oncology patients with a pacemaker, implantable cardioverter defibrillator or non-cardiac active implantWim P A Jansen, Phil W Koken, Renske A de Jong, et al.
The American Journal of Cardiology|September 3, 2016
Long-Term Echocardiographic Outcome in Super-Responders to Cardiac Resynchronization Therapy and the Association With Mortality and Defibrillator TherapyAafke C van der Heijden, Ulas Höke, Joep Thijssen, et al.
Heart Rhythm|March 3, 2009
Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapyC Jan Willem Borleffs, Claudia Ypenburg, Rutger J van Bommel, et al.
Journal of Cardiovascular Electrophysiology|July 23, 2011
Primary prevention implantable cardioverter defibrillator recipients: the need for defibrillator back-up after an event-free first battery service-lifeGuido H Van Welsenes, Johannes B Van Rees, Joep Thijssen, et al.
The American Journal of Cardiology|August 6, 2002
Effectiveness of resynchronization therapy in patients with end-stage heart failureSander G Molhoek, Jeroen J Bax, Lieselot van Erven, et al.
Journal of the American College of Cardiology|January 29, 2011
Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortalityJohannes B van Rees, C Jan Willem Borleffs, Mihály K de Bie, et al.
European Heart Journal|January 25, 2012
Predictors of long-term benefit of cardiac resynchronization therapy in patients with right bundle branch blockDarryl P Leong, Ulas Höke, Victoria Delgado, et al.
The American Journal of Cardiology|March 31, 2004
Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathySander G Molhoek, Jeroen J Bax, Lieselot van Erven, et al.
Journal of Cardiovascular Electrophysiology|July 14, 2006
Serial reevaluation for ARVD/C is indicated in patients presenting with left bundle branch block ventricular tachycardia and minor ECG abnormalitiesPhilippine Kiès, Marianne Bootsma, Jeroen J Bax, et al.
Pageof 12